Archivio Categoria: venture capital funding

Detection Technology Completes Acquisition of Haobo Imaging

CHINA – Detection Technology, an Espoo, Finland-based provider of X-ray detector solutions and services, acquired Haobo Imaging, a Shanghai, China-based company which specializes in static and dynamic TFT flat panel detectors. Detection Technology acquired 90% of the shares in Haobo Imaging for EUR 12M. The founders and management of Haobo Imaging will continue to hold […]

Ermes Cyber Security Raises €3M in Series A Funding

ITALY – Ermes Cyber Security, a Turin, Italy-based AI powered cybersecurity company, raised €3m in Series A funding. The round, whose closing is expected for the end of the year, was led by Sinergia Venture Fund.The company intends to use the funds to expand abroad and invest in the product, research, communication and marketing efforts.Led […]

Planckian Closes €2.7M Pre-Seed Funding

ITALY – Planckian, a Pisa, Italy-based startup focused on advancing quantum batteries, raised €2.7M in Pre-Seed funding. The round was led by Eureka! Venture, with the participation of CDP Venture, Exor Ventures and angel investors.The company intends to use the funds to expand operations and its development efforts.Led by Michele Dallari, CEO, Marco Polini, CSO, […]

Nordson to Acquire Arag, At EV of €960M

ITALY – Nordson Corporation (Nasdaq: NDSN), a Westlake, OH-based precision technology company, acquired Arag Group, a Rubiera, Italy-based company which specializes in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. The all-cash transaction values Arag at an enterprise value of €960M. With the acquisition, Nordson will expand […]

Muscope Raises €800K Funding Round

ITALY – Muscope Cybersecurity Srl, a Milan, Italy-based cybersecurity startup, closed a €800k in funding. Backers included Primo Ventures SGR S.p.A., through Primo Digital and Primo Digital Parallel Italia, joined by Klecha & Co., a pan-European investment bank, through Cyber K1. The company intends to use the funds to accelerate product development, extend its data analysis efforts […]

Bicycle Capital Launches $500M Inaugural Fund; Approximately $440M Already Committed

Bicycle Capital, a new growth equity firm focused on Latin America, launched its first fund, Bicycle I, with initial commitments of approximately US$440M, targeting a total fund size of US$500M. Anchor commitments came from Claure Group, Marcelo Claure’s Family Office, and Mubadala Investment Company. Led by Marcelo Claure as Executive Chairman and Managing Partner alongside Mwashuma (“Shu”) Nyatta as Managing Partner, Bicycle […]

Eccogene Raises CNY 180M in Series B Equity Financing

CHINA – Eccogene, a Shanghai, China-based clinical-stage biotechnology company, raised CNY180M (approx. $25M) in Series B Equity funding. The round by co-led by New Alliance Capital and Zhangjiang Healthcare Venture Capital. The syndicate also included new investors Rockbleu Capital, YuFu Investment, Huajin Capital, Elikon Venture and existing investors Delos Capital, Oriza Seed Capital and Qingsong […]

AAVantgarde Bio Closes €61M Series A Financing

AAVantagarde Bio, a Milan, Italy-based clinical-stage, biotechnology company developing two proprietary Adeno-Associated Viral (AAV) vector platforms, raised €61M in Series A funding. The round was co-led by Atlas Venture and Forbion, with participation from Longwood Fund and founding investor Sofinnova Partners through its Sofinnova Telethon Fund. In connection with the Series A financing, Jason Rhodes […]

Lynk Pharmaceuticals Completes 200M RMB Series C1 Financing

CHINA – Lynk Pharmaceuticals, a Hangzhou, China-based clinical stage company, raised 200M RMB in Series C1 funding. The round saw participation from China Grand Prosperity Investment, Tailong Capital and Liando Investment. The company intends to use the funds to accelerate the clinical development of its core products.Led by Dr. Zhao-Kui (ZK) Wan, Chairman and CEO, […]

LTZ Therapeutics Raises Over $10M in Pre-A+ Financing

CHINA – LTZ Therapeutics, a Redwood City, CA- and Shenzen, China-based immunotherapy-focused biotech company, raised over $10m in pre-A+ financing. The round was led by Qiming Venture Partners, with participation from Shunwei Capital, Lihehongxin Venture Capital Partnership and K2 Venture Partners. The closing of this round brings LTZ’s total funding to approximately $30m since the […]